Literature DB >> 12193229

Characterization, expression and functional aspects of a novel protein tyrosine phosphatase epsilon isoform.

T Wabakken1, H Hauge, S Funderud, H C Aasheim.   

Abstract

This report describes the identification and characterization of a novel cytoplasmic isoform of human protein tyrosine phosphatase epsilon (PTPepsilon). The novel isoform, denoted cyt-PTPepsilonPD1, displays only the N-terminal catalytic, active phosphatase domain 1 (PD1) which is common in all known PTPepsilon isoforms. In addition, it contains a unique 132-residue long C-terminal end with no known motifs or homology to other characterized proteins. RNAse protection assay on isolated leucocyte subpopulations and selected cell lines demonstrated highest expression of cyt-PTPepsilonPD1 in monocytes. The mRNA-encoding cyt-PTPepsilonPD1 is detected as distinct transcript(s) by Northern blot analysis and is a result of alternative splicing. cyt-PTPepsilonPD1 shows similar cellular localization in transfected cells, both in the cytoplasm and nucleus, as has been previously described for cytoplasmic PTPepsilon isoform. Our previous data suggest that the expression of cytoplasmic PTPepsilon inhibits the mitogen-activated protein kinase cascade through the extracellular signal-regulated kinase 1 and 2 pathway. A similar functional role is also presented here for cyt-PTPepsilonPD1, supporting our previous data suggesting that the catalytic first PD of PTPepsilon is responsible for this inhibition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193229     DOI: 10.1046/j.1365-3083.2002.01127.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Epidermal growth factor receptor (EGFR)-mediated positive feedback of protein-tyrosine phosphatase epsilon (PTPepsilon) on ERK1/2 and AKT protein pathways is required for survival of human breast cancer cells.

Authors:  Caroline E Nunes-Xavier; Ari Elson; Rafael Pulido
Journal:  J Biol Chem       Date:  2011-11-23       Impact factor: 5.157

2.  High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design.

Authors:  George T Lountos; Sreejith Raran-Kurussi; Bryan M Zhao; Beverly K Dyas; Terrence R Burke; Robert G Ulrich; David S Waugh
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-10-02       Impact factor: 7.652

3.  A new ephrin-A1 isoform (ephrin-A1b) with altered receptor binding properties abrogates the cleavage of ephrin-A1a.

Authors:  Eivind F Finne; Else Munthe; Hans-Christian Aasheim
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

4.  Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array.

Authors:  Helena Nord; Christian Hartmann; Robin Andersson; Uwe Menzel; Susan Pfeifer; Arkadiusz Piotrowski; Adam Bogdan; Wojciech Kloc; Johanna Sandgren; Tommie Olofsson; Göran Hesselager; Erik Blomquist; Jan Komorowski; Andreas von Deimling; Carl E G Bruder; Jan P Dumanski; Teresita Díaz de Ståhl
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

5.  Differential use of signal peptides and membrane domains is a common occurrence in the protein output of transcriptional units.

Authors:  Melissa J Davis; Kelly A Hanson; Francis Clark; J Lynn Fink; Fasheng Zhang; Takeya Kasukawa; Chikatoshi Kai; Jun Kawai; Piero Carninci; Yoshihide Hayashizaki; Rohan D Teasdale
Journal:  PLoS Genet       Date:  2006-04-28       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.